PT1847256E - Composições antibacterianas para o tratamento de infeções das vias respiratórias superiores e inferiores - Google Patents

Composições antibacterianas para o tratamento de infeções das vias respiratórias superiores e inferiores Download PDF

Info

Publication number
PT1847256E
PT1847256E PT70072723T PT07007272T PT1847256E PT 1847256 E PT1847256 E PT 1847256E PT 70072723 T PT70072723 T PT 70072723T PT 07007272 T PT07007272 T PT 07007272T PT 1847256 E PT1847256 E PT 1847256E
Authority
PT
Portugal
Prior art keywords
infections
treatment
lower airways
antibacterial compositions
antibacterial
Prior art date
Application number
PT70072723T
Other languages
English (en)
Inventor
Patrizia Pattini
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38016848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1847256(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Publication of PT1847256E publication Critical patent/PT1847256E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT70072723T 2006-04-13 2007-04-06 Composições antibacterianas para o tratamento de infeções das vias respiratórias superiores e inferiores PT1847256E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000742A ITMI20060742A1 (it) 2006-04-13 2006-04-13 Composizioni antibatteriche per il trattamento di infezioni delle alte e basse via aeree

Publications (1)

Publication Number Publication Date
PT1847256E true PT1847256E (pt) 2014-07-15

Family

ID=38016848

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70072723T PT1847256E (pt) 2006-04-13 2007-04-06 Composições antibacterianas para o tratamento de infeções das vias respiratórias superiores e inferiores

Country Status (9)

Country Link
EP (2) EP2111855B1 (pt)
DK (1) DK1847256T3 (pt)
ES (2) ES2604212T3 (pt)
HU (1) HUE031098T2 (pt)
IT (1) ITMI20060742A1 (pt)
LT (1) LT2111855T (pt)
PL (2) PL1847256T3 (pt)
PT (1) PT1847256E (pt)
SI (1) SI2111855T1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006049580A1 (de) * 2006-10-20 2008-04-24 Rochel, Michael, Dr. med. Topische Zusammensetzung zur Behandlung von Ekzemen
DE102008007198A1 (de) 2008-02-01 2009-08-13 Infectopharm Arzneimittel Und Consilium Gmbh Oral oder nasal applizierbare Epinephrin- haltige Zubereitungen mit verbesserten Eigenschaften
IT1401494B1 (it) * 2010-07-30 2013-07-26 Eupharma Srl Formulazioni inalatorie in forma di soluzioni o polveri secche, per la rimozione delle secrezioni mucose dall'apparato respiratorio
ES2437690B1 (es) * 2012-07-10 2014-10-24 Chiesi Farmaceutici S.P.A. Formulaciones inhalatorias en forma de soluciones o de polvos secos, para la eliminación de las secreciones mucosas del aparato respiratorio
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP2985027B1 (en) * 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
GB201611639D0 (en) 2016-07-04 2016-08-17 Ockham Biotech Ltd Delivery device and formulation
IT202000016984A1 (it) 2020-07-13 2022-01-13 Bmg Pharma S P A Composizioni igienizzanti e antiinfettive per le mucose orali

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
US20040009126A1 (en) * 2002-03-05 2004-01-15 Transave, Inc. Inhalation system for prevention and treatment of intracellular infections
FR2847818B1 (fr) 2002-11-28 2008-04-04 Agro Ind Rech S Et Dev Ard Composition pharmaceutique a base d'acide hyaluronique
US7452524B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation

Also Published As

Publication number Publication date
PL2111855T3 (pl) 2017-02-28
EP1847256A1 (en) 2007-10-24
SI2111855T1 (sl) 2016-12-30
ES2482815T3 (es) 2014-08-04
ITMI20060742A1 (it) 2007-10-14
EP2111855B1 (en) 2016-08-31
EP1847256B1 (en) 2014-04-23
EP2111855A1 (en) 2009-10-28
LT2111855T (lt) 2016-12-12
DK1847256T3 (da) 2014-06-30
HUE031098T2 (hu) 2017-07-28
PL1847256T3 (pl) 2014-09-30
ES2604212T3 (es) 2017-03-03

Similar Documents

Publication Publication Date Title
HK1134679A1 (zh) 用於治療感染的組合物和方法
IL257622B (en) Methods and preparations for the treatment of persistent infections
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
HK1156038A1 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
EP2043620A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS
GB0718446D0 (en) Compositions and methods for the treatment of infection
IL195272A0 (en) Methods and compositions for the treatment of viral infections
SI2111855T1 (sl) Antibakterijski sestavki za zdravljenje okužb zgornjih in spodnjih dihalnih poti
HK1161886A1 (en) Novel antibacterial agents for the treatment of gram positive infections
EP2217238A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA
GB0909297D0 (en) Composition for the treatment of skin conditions
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
EP2231146A4 (en) Pharmaceutical composition for the treatment and prevention of glaucoma
IL208848A0 (en) Compositions for the treatment and prevention of infections of the oral cavity
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2271328A4 (en) ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS
EP1865952A4 (en) COMPOSITIONS CONTAINING HISTAMINES FOR THE TREATMENT OF ALLERGIES
EP2117586A4 (en) TREATMENT OR PROPHYLAXIS OF ASTHMA
EP1838216A4 (en) PREVENTION OF RESPIRATORY INFECTIONS IN POULTRY
GB0602857D0 (en) The treatment of sialorrhoea
GB0618309D0 (en) Compositions and methods for the treatment of disease
GB0602871D0 (en) Use Of Anti-Microbial Compositions And Novel Methods For The Delivery Of Such Compositions
GB0602855D0 (en) The Treatment Of Sialorrhoea
GB0602858D0 (en) The treatment of sialorrhoea
EP2276502A4 (en) COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROLOGICAL INJURIES AND ASSOCIATED METHODS OF USE